Table 7.
Adverse Event | Duration After Initial Treatment | Incident Cases |
Incident Proportion |
||
---|---|---|---|---|---|
Men | Women | Total | Total | ||
Endophthalmitis | In 1 yr | 81 | 51 | 132 | 0.054% |
In 2 yrs | 105 | 65 | 170 | 0.069% | |
In 3 yrs | 122 | 78 | 200 | 0.081% | |
Retinal detachment | In 1 yr | 326 | 142 | 468 | 0.19% |
In 2 yrs | 460 | 198 | 658 | 0.26% | |
In 3 yrs | 549 | 229 | 778 | 0.32% |
VEGF = vascular endothelial growth factor.
Endophthalmitis and retinal detachment were defined on the basis of diagnosis codes and pars plana vitrectomy (PVV).
Incident proportions were calculated by dividing the number of incident cases by the number of patients who received anti-VEGF injections as the initial treatment for AMD (n = 246 064).